Frontlight ResearchEarly access
Trial site
Affiliated Zhongshan Hospital of Fudan University
- 6running trials
- 12closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia5 trials
- Lung cancer4 trials
- Diffuse large B-cell lymphoma3 trials
- Liver and biliary tract cancer3 trials
- Follicular lymphoma2 trials
- Gastric and oesophageal cancer2 trials
- Bladder cancer1 trial
- Head and neck cancer1 trial
- Mantle cell lymphoma1 trial
- Multiple myeloma1 trial
- Phase
- Phase 37 trials
- Phase 26 trials
- Phase 1/23 trials
- Phase 12 trials
- Status
- Completed9 trials
- Active, not recruiting4 trials
- Terminated3 trials
- Recruiting2 trials
- Lead sponsor
- BeiGene13 trials
- BeOne Medicines4 trials
- Jazz Pharmaceuticals1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Terminated
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026